BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15334068)

  • 1. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer.
    Petroziello J; Yamane A; Westendorf L; Thompson M; McDonagh C; Cerveny C; Law CL; Wahl A; Carter P
    Oncogene; 2004 Oct; 23(46):7734-45. PubMed ID: 15334068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization.
    Sun W; Zhang K; Zhang X; Lei W; Xiao T; Ma J; Guo S; Shao S; Zhang H; Liu Y; Yuan J; Hu Z; Ma Y; Feng X; Hu S; Zhou J; Cheng S; Gao Y
    Cancer Lett; 2004 Aug; 212(1):83-93. PubMed ID: 15246564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
    Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
    Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially expressed genes associated with human lung cancer.
    Xiao W; Pacyna-Gengelbach M; Schlüns K; An Q; Gao Y; Cheng S; Petersen I
    Oncol Rep; 2005 Jul; 14(1):229-34. PubMed ID: 15944794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metastasis-associated genes in early stage non-small cell lung cancer by subtractive hybridization.
    Wang WB; Böing S; Zhou XQ; Ji P; Dong Y; Yao Q; Müller-Tidow C
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):273-8. PubMed ID: 12019437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non small cell lung cancer gene expression profiles by cDNA microarrays].
    Ouyang QC; Hu CP; Shi LJ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):9-12. PubMed ID: 12934383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and contrasting genomic profiles among the major human lung cancer subtypes.
    Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA
    Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of GIMAP genes in non-small cell lung cancer.
    Shiao YM; Chang YH; Liu YM; Li JC; Su JS; Liu KJ; Liu YF; Lin MW; Tsai SF
    Lung Cancer; 2008 Dec; 62(3):287-94. PubMed ID: 18462827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.
    Kuner R; Muley T; Meister M; Ruschhaupt M; Buness A; Xu EC; Schnabel P; Warth A; Poustka A; Sültmann H; Hoffmann H
    Lung Cancer; 2009 Jan; 63(1):32-8. PubMed ID: 18486272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
    Blackhall FH; Wigle DA; Jurisica I; Pintilie M; Liu N; Darling G; Johnston MR; Keshavjee S; Waddell T; Winton T; Shepherd FA; Tsao MS
    Lung Cancer; 2004 Nov; 46(2):197-204. PubMed ID: 15474668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
    Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
    Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.